Additionally, compounded semaglutide may no longer be available due to FDA restrictions, making Wegovy a more accessible and trusted alternative
Product Specifications Both products are 99%+ purity, third-party verified by Janoshik Analytical via HPLC and mass spectrometry
However, their high metabolic risks, including weight gain, diabetes, and lipid abnormalities, 1 deter treatment adherence 2 and increase cardiovascular disease risk and related mortality, 3,4 making it challenging for clinicians to balance psychiatric and physical health
When used for NASH, dual agonists decrease hepatic fat levels, enhance insulin sensitivity, and combat hepatic pathological complications (Monfeuga et al., 2024)
Although GLP-1s are considered peptides, they will not be included
Titles and abstracts were then screened, leading to the exclusion of 801 reviews and 1,102 articles considered off-topic because they did not involve pediatric populations, or chronic conditions